Tirzepatide
-
Post Date:
Sep 15,2025
-
Expiry Date:
Mar 14,2026
-
Detailed Description:
Cas No. :2023788-19-2
Specs:99%up,DMF
Tirzepatide is the world's first dual GIP/GLP-1 receptor agonist. It exerts its therapeutic effects by simultaneously targeting two key receptors:
(1) Glucose-dependent insulinotropic polypeptide (GIP) receptor: Enhances insulin secretion and suppresses glucagon, improving glycemic control.
(2) Glucagon-like peptide-1 (GLP-1) receptor: Delays gastric emptying, increases satiety, and promotes glucose-dependent insulin release.
This dual mechanism provides synergistic metabolic benefits, demonstrating superior efficacy compared to single-target agents.
-
CAS Registry Number:
2023788-19-2
-
Synonyms:
;Tianeptine Sodium;
Inquiry